Management Team



Michael T. Fiore – Chief Executive Officer and Co-Founder

Mr. Fiore founded Vantage Oncology in 2002 in collaboration with Dr. Leslie Botnick. He has more than 25 years of experience in the development and operation of cancer treatment facilities. Mr. Fiore and his team have successfully grown Vantage into a national organization.  In January 2011, Vantage completed an equity recapitalization with Oak Hill Capital Partners and a merger with Physician Oncology Services, creating the second largest radiation oncology company in the United States.

Mr. Fiore was previously the COO of Salick Health Care, a publicly traded cancer and dialysis services company with over 30 sites, and President of its cancer center subsidiary, prior to its successful sale to Astra Zeneca in 1997.  He has also served as CEO of InterDent, an owner and operator of 350 dental facilities throughout the United States, and as Vice President of American Medical International (now Tenet Healthcare), an owner and operator of hospitals. Mr. Fiore is a Director of the Cancer Support Community - South Bay Cities, a non-profit organization that provides a professional program of support, education and hope to cancer patients and their families free of charge. Mr. Fiore has a MBA from Harvard University, a BA in Economics and Anthropology from Amherst College and an MS in Accounting from New York University. He is a Certified Public Accountant. Mr. Fiore was named a 2010 Ernst & Young Entrepreneur of the Year Award Winner for the Greater Los Angeles Area. 

 
Michael Fiore - Chairman & CEO


Leslie E. Botnick, MD Chief Medical Officer and Co-Founder


A board certified Radiation Oncologist practicing at The Center for Radiation Therapy of Beverly Hills, Dr. Botnick is Co-Founder and Chief Medical Officer of Vantage Oncology.  In addition, he is the Chief Executive Officer and Founder of Valley Radiotherapy Associates Medical Group.  Previously at the Beth Israel Hospital in Boston, Dr. Botnick was Medical Director of Radiation Oncology.

With more than 40 publications on Breast Cancer, Hodgkin’s disease, Head and Neck Cancer and Hematopoietic Stem Cell Repair, he is named as a leading physician for the treatment of Breast Cancer in Good Housekeeping Magazine and listed in Who’s Who of Doctors in America.  In addition, Dr. Botnick is associated with several Health Systems throughout Los Angeles, Orange and Riverside counties in California, including the nationally renowned John Wayne Cancer Institute.  His areas of expertise include: Breast, Prostate, Lung, Head and Neck, Pancreatic, and Colorectal Cancer as well as Hodgkin’s and Non-Hodgkin’s Lymphoma. 

At Metropolitan Hospital in New York, he served an internship in internal medicine and did his residency at the Harvard Joint Center for Radiation Therapy in Boston where he later became Chief Resident.  Dr. Botnick earned a Bachelors of Arts Degree from Brooklyn College followed by a Medical Degree from New York Medical College.

 
Leslie E. Botnick, MD – Chief Medical Officer


Marshal D. Salomon Chief Operating Officer


Mr. Salomon was named Chief Operating Officer in October 2013.  He had previously been Vantage's CFO since 2002 and has been a key driver of the company's success. Mr. Salomon is responsible for overseeing the operations of our nationwide network. He is also responsible for a number of operations-facing departments such as Physics, Reimbursement Operations, Strategic Support Services, Information Technology and Human Resources, among others.

Prior to Vantage, Marshal was Vice President of both Finance and Corporate Development at DaVita, Inc. (NYSE: DVA), the second largest provider of dialysis services in the United States. Formerly, Mr. Salomon was Vice President and General Manager of Columbia Medical Mfg. Corp., a manufacturer and marketer of rehabilitation equipment. Mr. Salomon earned a MBA from The Anderson School at UCLA and a BA in Economics from Brown University.

 
Marshal D. Salomon – President, Western Division and Chief Operating Officer

Mark Ahern Chief Development Officer

Mr. Ahern joined Vantage Oncology as Chief Development Officer in 2005. He is the former President of First Circle Medical, Inc.; a medical device company focused on developing treatments for Hepatitis C. Previously, Mr. Ahern was Senior Vice President of Corporate Development for US Oncology, a large healthcare services network dedicated to cancer treatment and research. While at US Oncology, Mr. Ahern was responsible for acquisitions, joint ventures and strategic alliances. At the time of his departure in 2000, US Oncology had grown to over 900 affiliated physicians, 460 practice locations and 85 free-standing cancer centers encompassing 32 states. Mr. Ahern earned his BA from the University of Arizona.

 
Mark Ahern – Chief Development Officer

Brian Rizkallah – Chief Financial Officer

Mr. Rizkallah was named Interim CFO in October 2013. Mr. Rizkallah joined Vantage Oncology for a second time in 2011 as Vice President, Finance, overseeing Vantage Oncology’s relationships with its debt and equity capital sources. From 2004-2006, he was the Company's first finance and corporate development analyst, where he helped secure the Company's early stage investments and execute its initial acquisitions.

Prior to returning to Vantage in 2011, Mr. Rizkallah was an Associate and later Vice President at FocalPoint Partners, a boutique middle-market investment bank. At FocalPoint, he advised management teams regarding mergers & acquisitions, capital raises and restructurings. Prior to his initial time with Vantage in 2004, Mr. Rizkallah was a financial analyst at Chanin Capital Partners, a boutique investment bank since acquired by Duff & Phelps. While at Chanin, he primarily advised bondholders and other creditors in large, corporate restructurings and reorganizations. Mr. Rizkallah earned an MBA from the UCLA Anderson School of Management and a BA in Business-Economics and Political Science from UCLA.

 
Brian Rizkallah – Vice President, Finance


Veeral Desai – President, Operations


Mr. Desai joined Vantage Oncology in 2011, serving as a key agent of change for the company until being named President, Operations in 2013. Veeral oversees the two largest regions of the network, the West and Southeast. He co-led Vantage’s largest integration in its history with the acquisition of the ROSA network in 2013. In addition, he is responsible for marketing, which includes both physician network development and direct-to-patient outreach programs. Veeral also leads strategic planning, which includes Vantage’s operations strategy and business analytics group.

Prior to joining Vantage, he was a Manager at Bain and Company where he served healthcare, technology, and private equity clients. While at Bain, he specialized in strategic and operational issues facing healthcare organizations spanning providers, payers, and medtech. Mr. Desai holds a MBA from Harvard Business School and BS in Business Administration from University of California, Berkeley.
 

 
 Veeral Desai – Vice President, Operations Strategy and Development

Christopher M. Rose, MD, FACR Chief Technology Officer

A board certified Radiation Oncologist, Dr. Rose serves both as Chief Technology Officer at Vantage Oncology and Medical Director of The Center for Radiation Therapy of Beverly Hills.  In addition, Dr. Rose is both the Technical and Associate Director of Valley Radiotherapy Associates Medical Group and a Co-Founder of Vantage Oncology.  Currently, Dr. Rose is a member of the Medicare Coverage Advisory Commission and Vice Chair of the NCI-sponsored Quality Research in Radiation Oncology Study. With more than 50 articles on the treatment of Prostate Cancer, Breast Cancer, Head and Neck Cancer and physico-chemical methods of radiation sensitization, Dr. Rose is one of three radiation oncologists to receive the Donald Coffey Clinician Scientist Award from the Prostate Cancer Foundation. In addition, he is the 2008 Gold Medalist of the American Society of Therapeutic Radiology and Oncology and is listed in Best Doctors in America.

At the Institute for Cancer Research, Royal Marsden Hospital, University of London in Great Britain, Dr. Rose was a Visiting Clinical Scientist.  Previously, he was an Assistant Professor of Radiation Oncology at Harvard Medical School and was Chairman of the Board of Directors and President of the American Society of Therapeutic Radiology and Oncology (ASTRO), the professional society of Radiation Oncology.

For the California Medicare Carrier and advisor to the Health Care Financing Agency Clinical Practice Expense Panel, Dr. Rose was the Expert Physician reviewer for radiation oncology.  He is Past President of the Council of Affiliated Regional Radiation Oncology Societies of the American College of Radiology, Past President of the California Radiation Oncology Society, and Counselor of the American College of Radiology.  

At the Beth Israel Hospital in Boston, Dr. Rose served an internship and residency in Internal Medicine followed by a residency in Radiation Oncology at the Harvard Joint Center for Radiation Therapy. His areas of expertise include Prostate, Breast, Skin, Rectal, Esophageal, and Lung Cancer as well as Bone Metastases. Dr. Rose earned  his M.D. from Harvard Medical School and his Bachelor of Science from the Massachusetts Institute of Technology.   


 
Christopher M. Rose, MD, FACR – Chief Technology Officer
 

Steve Udicious - General Counsel

After serving as outside counsel to Vantage Oncology for four years, Mr. Udicious joined the company as General Counsel in 2007. While at DaVita and its predecessor companies, Total Renal Care and Renal Treatment Centers, from 1997 to 2003, he was a member of the legal department and became General Counsel in 2000. Following his work with DaVita, Mr. Udicious opened his own private law practice. Prior to DaVita, Mr. Udicious worked at Duane Morris LLP, a large Philadelphia law firm. Mr. Udicious earned a JD from The Temple University School of Law and a Bachelor of Science from Washington & Lee University.

 
Steve Udicious - General Counsel

Ben Slocum – President, Vantage Cancer Care Network

Mr. Slocum is the President of Vantage Cancer Care Network (VCCN), a provider of advanced oncology services that brings multispecialty providers together in collaboration to manage the entire patient cancer episode. VCCN is committed to Vantage Oncology’s model of patient-centered, integrated oncology care, helping to develop a premier cancer treatment delivery system, focused solely on providing patients the best clinical outcomes and personalized care.

Prior to Joining Vantage, Mr. Slocum served as a consultant for both Oak Hill Capital Partners and HES Advisors informing strategy for clients in the Healthcare sector. Formerly, Mr. Slocum held the role of CEO for Lovelace Health Plan in Albuquerque, New Mexico. Lovelace, a premier and historic multiline health plan serving Medicare, Medicaid and commercial members throughout New Mexico and Oklahoma was recently sold to HCSC. Prior to joining Lovelace Health Plan, he served as CEO of UnitedHealthcare of Northern California, a company that organizes access to health care for more than 25 million consumers and contracts with more than 600,000 health care providers and 5,000 hospitals.

 
Ben Slocum – President, Vantage Cancer Care Network

John Iacuone, MD - Chief Clinical Officer, Vantage Cancer Care Network

Dr. Iacuone is Chief Clinical Officer, Vantage Cancer Care Network , a provider of advanced oncology services that brings multispecialty providers together in collaboration to manage the entire patient cancer episode. VCCN is committed to Vantage Oncology’s model of patient-centered, integrated oncology care, helping to develop a premier cancer treatment delivery system, focused solely on providing patients the best clinical outcomes and personalized care.

Dr. John Iacuone is a board certified pediatrician and sub-board certified hematologist-oncologist, with an MBA from Ralls School of Business TTU in Healthcare Management. He is well rounded, experienced medical executive, with a 360-degree view of healthcare. He has extensive primary and subspecialty clinical practice experience, as the employer and manager of a sub-specialty medical group, clinical research as the principal investigator for a National Cancer Organization, executive director of a hospital and outpatient servicer line for many years, and CMO experience in a health system and health plan including responsibility of Pharmacy Benefit Management (PBM), HCC, STARS and Quality NCQA accreditation.

He has over 20 years experience of progressive physician leadership and responsibilities in integrated Not-for Profit Health Systems (Covenant Health System, Lee Memorial Health System, and For-Profit System (Ardent Health Services as CMO of the health plan and hospitals for Lovelace health System). He is a nationally recognized expert in lean process application to patient flow and in value based benefit design, and on site clinic development with employer groups. He has formed relationships utilizing predictive modeling tools with provider groups in support in P4P, and patient centered medical home initiatives.

 
John Iacuone, MD - Chief Clinical Officer, Vantage Cancer Care Network

Mark Donovan – Sr. VP Strategic Planning and Business Development

With 15 years of health care experience as both an operator and investor, Mr. Donovan joined Vantage Oncology in 2008. His past experience includes Salix Ventures and Summit Partners, two prominent venture capital and private equity firms. Additionally, Mr. Donovan was instrumental in founding and growing, through its initial public offering, American Dental Partners, Inc. (NASD:ADPI). Mr. Donovan earned his MBA from the Harvard Business School and Bachelor of Arts in Architecture from Princeton University

Mark Donovan – Sr. VP Strategic Planning and Business Development

Joe Chang Vice President, Operational and Strategic Support Services

Since Vantage Oncology’s inception in 2002, Mr. Chang has been Vice President of Operational and Strategic Support Services & Controller. Formerly at InterDent, a publicly traded dental practice management company, he was the Director of Taxation. From 1997 until he left in 2002, the company grew to $360 million in revenue, 250 sites and in 16 states. Prior to joining InterDent, Mr. Chang held various positions in tax and accounting in both the private and public sectors. Mr. Chang earned an MA in Business Administration from the University of Phoenix and a Bachelor of Arts in Accounting from California State, Dominguez Hills.

 
Joe Chang - VP, Operations and Strategic Support Services & Controller

Richard Daversa Sr. Vice President, Operations

As Sr. Vice President of Operations, Mr. Daversa, manages operations for the Northeast and Midwest regions of the United States. Prior to joining Vantage Oncology, he was the Senior Vice President, Operations for Bentley Health Care, a privately held company specializing in the development and operation of outpatient centers focused on the management of catastrophic diseases (Cancer and HIV/AIDS). For over ten years, Mr. Daversa was the Vice President, Salick Health Care and was responsible for the operations of the South Florida Comprehensive Cancer Centers. While at Memorial Sloan Kettering Cancer Center for fourteen years, he held various administrative positions. Mr. Daversa earned an MA in Health Care Administration from Long Island University and a BA in Sociology from the State University of New York at Stony Brook.

 
Richard Daversa – Vice President, Operations - East


Maureen Murphy – Vice President, Human Resources


Ms. Murphy has been VP of Human Resources for Vantage Oncology since 2010. Previously, she was the VP of Human Resources and Risk Management at Pacific Dental Services, Inc. (PDS), a national leading dental management company. While with PDS, they were named one of Inc’s 500 Fastest Growing Companies in 2004 and remained in the top 500 in the Healthcare Sector from 2007-2010. Prior to leaving PDS, the company had grown to over 200 locations in five states employing 3500 people with approximate revenues of $350 million. Maureen previously worked at InterDent managing both HR and Risk Management. Ms. Murphy received her Bachelor of Arts with Cum Laude Honors from Hunter College (CUNY) and her HR Management from UCI, Irvine, CA.  Devoted to lifelong education, Maureen attends ongoing programs at Human Capital Institute.
 

 
 Maureen Murphy – Vice President, Human Resources